Eliquis MDL Judge Dismisses 74 Cases as Preempted by Federal Law

NEW YORK — The New York federal judge overseeing the Eliquis multidistrict litigation docket has dismissed 74 actions, ruling that the claims are preempted because the defendants were barred by federal law from unilaterally changing the Eliquis label to include additional warnings.

In a March 19 order, Judge Denise Cote of the U.S. District Court for the Southern District of New York also denied plaintiffs’ motion to remand the cases to state court, finding the amount in controversy requirement is met.

The Judicial Panel on Multidistrict Litigation created an MDL docket for all federal Eliquis actions on Feb. 7 and …